Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups
Authors
Keywords
Array-based comparative genomic hybridization, Astrocytoma, Gene expression profiles, Isocitrate dehydrogenase, Integrative bioinformatics, Oligodendroglioma, 1p/19q co-deletion
Journal
ACTA NEUROPATHOLOGICA
Volume 129, Issue 5, Pages 679-693
Publisher
Springer Nature
Online
2015-03-17
DOI
10.1007/s00401-015-1409-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas
- (2015) Yuchen Jiao et al. Oncotarget
- The genetic landscape of anaplastic astrocytoma
- (2015) Patrick J. Killela et al. Oncotarget
- Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas
- (2015) Patrick J. Killela et al. Oncotarget
- Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic glioma
- (2014) Benedikt Wiestler et al. ACTA NEUROPATHOLOGICA
- Farewell to oligoastrocytoma: in situ molecular genetics favor classification as either oligodendroglioma or astrocytoma
- (2014) Felix Sahm et al. ACTA NEUROPATHOLOGICA
- International Society of Neuropathology-Haarlem Consensus Guidelines for Nervous System Tumor Classification and Grading
- (2014) David N. Louis et al. BRAIN PATHOLOGY
- Molecular characterization of long-term survivors of glioblastoma using genome- and transcriptome-wide profiling
- (2014) Guido Reifenberger et al. INTERNATIONAL JOURNAL OF CANCER
- Benefit From Procarbazine, Lomustine, and Vincristine in Oligodendroglial Tumors Is Associated With Mutation ofIDH
- (2014) J. Gregory Cairncross et al. JOURNAL OF CLINICAL ONCOLOGY
- Assessing CpG island methylator phenotype, 1p/19q codeletion, and MGMT promoter methylation from epigenome-wide data in the biomarker cohort of the NOA-04 trial
- (2014) B. Wiestler et al. NEURO-ONCOLOGY
- ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis
- (2013) Benedikt Wiestler et al. ACTA NEUROPATHOLOGICA
- Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system
- (2013) Christian Koelsche et al. ACTA NEUROPATHOLOGICA
- Molecular neuro-oncology in clinical practice: a new horizon
- (2013) Michael Weller et al. LANCET ONCOLOGY
- Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma
- (2013) David T W Jones et al. NATURE GENETICS
- Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation
- (2013) W. Wick et al. NEUROLOGY
- Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutations
- (2012) Xiao-Yang Liu et al. ACTA NEUROPATHOLOGICA
- The Definition of Primary and Secondary Glioblastoma
- (2012) H. Ohgaki et al. CLINICAL CANCER RESEARCH
- Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402
- (2012) Gregory Cairncross et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951
- (2012) Martin J. van den Bent et al. JOURNAL OF CLINICAL ONCOLOGY
- Mining SOM expression portraits: feature selection and integrating concepts of molecular function
- (2012) Henry Wirth et al. BioData Mining
- Expression cartography of human tissues using self organizing maps
- (2011) Henry Wirth et al. BMC BIOINFORMATICS
- Gene expression in oligodendroglial tumors
- (2011) Elisabeth J. Shaw et al. CELLULAR ONCOLOGY
- Rapid and sensitive assessment of the IDH1 and IDH2 mutation status in cerebral gliomas based on DNA pyrosequencing
- (2010) Jörg Felsberg et al. ACTA NEUROPATHOLOGICA
- Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas
- (2010) Christian Hartmann et al. ACTA NEUROPATHOLOGICA
- Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician’s perspective
- (2010) Martin J. van den Bent ACTA NEUROPATHOLOGICA
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
- Update on molecular findings, management and outcome in low-grade gliomas
- (2010) T. David Bourne et al. Nature Reviews Neurology
- The Proneural Molecular Signature Is Enriched in Oligodendrogliomas and Predicts Improved Survival among Diffuse Gliomas
- (2010) Lee A. D. Cooper et al. PLoS One
- Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas
- (2009) Christian Hartmann et al. ACTA NEUROPATHOLOGICA
- Prognostic Significance of Molecular Markers and Extent of Resection in Primary Glioblastoma Patients
- (2009) J. Felsberg et al. CLINICAL CANCER RESEARCH
- Molecular Predictors of Progression-Free and Overall Survival in Patients With Newly Diagnosed Glioblastoma: A Prospective Translational Study of the German Glioma Network
- (2009) Michael Weller et al. JOURNAL OF CLINICAL ONCOLOGY
- NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide
- (2009) Wolfgang Wick et al. JOURNAL OF CLINICAL ONCOLOGY
- -Internexin expression identifies 1p19q codeleted gliomas
- (2009) F. Ducray et al. NEUROLOGY
- Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile
- (2008) Francois Ducray et al. Molecular Cancer
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started